|
||
Catalogue Number |
Product | Order number / Unit |
|
||
9855 | DOTA-NAPamide trifluoroacetate |
9855.0001: 1 mg per vial 9855.0010: 10 mg per vial Please inquire for customized filling and bulk quantities. ![]() |
Precursor for radiolabelled DOTA-NAPamide
|
||
Molar Mass: 1485.65 | ||
C68H100N20O18 | ||
[935886-72-9] (net peptide) | ||
Colourless to off-white freeze-dried solid packaged in screw cap vials. | ||
Purity: ≥ 95 % | ||
Certificates:
CoA; MS (identity); HPLC (purity) |
||
Chemical Name: Sequence: Ac-Nle-Asp-His-D-Phe-Arg-Trp-Gly-Lys(DOTA)-NH2 |
||
Synonymes: [Nle4,Asp5,D-Phe7, Lys11(DOTA)]-α-MSH(4-11); CA index name: L-Lysinamide, N-acetyl-L-norleucyl-L-α-aspartyl-L-histidyl-D-phenylalanyl-L-arginyl-L-tryptophylglycyl-N6-[2-[4,7,10-tris(carboxymethyl)-1,4,7,10-tetraazacyclododec-1-yl]acetyl]- |
||
Literature: Froidevaux S. et al. A Gallium-Labeled DOTA-α-Melanocyte-Stimulating Hormone Analog for PET Imaging of Melanoma Metastases. J. Nucl. Med. 2004, 45, 116-123. |
||
Froidevaux S. et al. Melanoma Targeting with DOTA-α-Melanocyte-Stimulating Hormone Analogs: Structural Parameters Affecting Tumor Uptake and Kidney Uptake. J. Nucl. Med. 2005, 46, 887-895. | ||
Cheng Z. et al. Cu-Labeled α-Melanocyte-Stimulating Hormone Analog for MicroPET Imaging of Melanocortin 1 Receptor Expression. Bioconjugate Chem. 2007, 18, 765-772. | ||
date of product catalogue issue: 10 May 2017 |